Haisco Pharmaceutical Group Co., Ltd.
002653
Peringkat dalam Saham
#2010
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Harga Saham
$9.03
Kapitalisasi Pasar
$10.30B
Perubahan (1 hari)
4.55%
Perubahan (1 tahun)
24.15%
Negara
CN
Perdagangan Haisco Pharmaceutical Group Co., Ltd. (002653)
Kategori
Healthcare
Jumlah saham beredar untuk Haisco Pharmaceutical Group Co., Ltd. (002653)
Jumlah saham beredar per June 2026: 1.12B
Menurut laporan keuangan terbaru dan harga saham Haisco Pharmaceutical Group Co., Ltd., jumlah saham beredar saat ini adalah 1.12B. Pada akhir December 2023, perusahaan memiliki 1.09B saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Haisco Pharmaceutical Group Co., Ltd. (002653) dari 2008 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 1.12B | 0.00% |
| 2024 | 1.12B | 2.46% |
| 2023 | 1.09B | 1.62% |
| 2022 | 1.08B | -0.10% |
| 2021 | 1.08B | 0.66% |
| 2020 | 1.07B | 0.00% |
| 2019 | 1.07B | 0.00% |
| 2018 | 1.07B | 0.00% |
| 2017 | 1.07B | 0.00% |
| 2016 | 1.07B | 0.59% |
| 2015 | 1.06B | -0.88% |
| 2014 | 1.07B | -0.83% |
| 2013 | 1.08B | 0.10% |
| 2012 | 1.08B | 11.50% |
| 2011 | 969.19M | 2.14% |
| 2010 | 948.89M | 4.05% |
| 2009 | 911.96M | 0.42% |
| 2008 | 908.16M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | -77.33% |
US
|
|
| 396.00M | -64.64% |
US
|
|
| 478.91M | -57.24% |
AU
|
|
| 62.19M | -94.45% |
NL
|
|
| - | - |
CH
|
